CN Stock MarketDetailed Quotes

301408 Anhui Huaren Health Pharmaceutical

Watchlist
  • 10.59
  • -0.76-6.70%
Market Closed Sep 6 15:00 CST
4.24BMarket Cap32.79P/E (TTM)

Anhui Huaren Health Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
25.21%2.17B
30.60%1.1B
16.39%3.8B
19.71%2.68B
22.80%1.73B
24.91%845.61M
39.50%3.26B
39.17%2.24B
36.90%1.41B
35.28%676.98M
Operating revenue
25.21%2.17B
30.60%1.1B
16.39%3.8B
19.71%2.68B
22.80%1.73B
24.91%845.61M
39.50%3.26B
39.17%2.24B
36.90%1.41B
35.28%676.98M
Other operating revenue
2.26%34.32M
----
22.53%74.42M
----
5.17%33.56M
----
-12.55%60.74M
----
--31.91M
----
Interest income
--0
----
----
--0
--0
----
----
--0
--0
----
Commission income
--0
--0
--0
--0
--0
--0
--0
--0
--0
----
Premiums earned
--0
--0
--0
--0
--0
--0
--0
--0
--0
----
Total operating cost
24.74%2.07B
28.08%1.03B
19.81%3.66B
19.82%2.57B
22.73%1.66B
23.37%806.31M
35.71%3.05B
2.15B
1.35B
653.57M
Operating cost
24.50%1.48B
29.96%741.62M
19.73%2.63B
19.52%1.83B
24.10%1.19B
25.35%570.67M
44.41%2.2B
--1.53B
--955.87M
--455.28M
Operating tax surcharges
65.13%10.23M
61.59%4.98M
-2.91%16.72M
-4.84%10.55M
-12.15%6.19M
-8.98%3.08M
31.20%17.22M
--11.09M
--7.05M
--3.39M
Operating expense
22.83%467.5M
23.53%229.48M
22.18%804.47M
26.46%592.82M
24.33%380.61M
21.20%185.76M
18.29%658.43M
--468.76M
--306.13M
--153.26M
Administration expense
21.53%92.5M
13.76%45.54M
5.59%158.51M
0.42%114.83M
5.33%76.12M
13.34%40.03M
14.20%150.12M
--114.35M
--72.27M
--35.32M
Financial expense
26.36%10.13M
3.56%4.9M
-14.76%19.35M
-23.75%13.57M
-33.15%8.01M
-21.97%4.73M
-6.06%22.7M
--17.8M
--11.99M
--6.06M
-Interest expense (Financial expense)
54.40%6.47M
77.74%4.25M
77.65%12.24M
97.86%7.03M
31.83%4.19M
193.93%2.39M
43.59%6.89M
--3.55M
--3.18M
--812.6K
-Interest Income (Financial expense)
-38.58%-8.9M
-80.81%-4.63M
-228.38%-14.07M
-247.52%-7.88M
-398.53%-6.42M
-2,126.32%-2.56M
-121.21%-4.28M
---2.27M
---1.29M
---114.94K
Research and development
255.75%15.4M
205.62%6.2M
480.42%24.19M
286.64%8.85M
729.43%4.33M
705.83%2.03M
735.76%4.17M
--2.29M
--521.95K
--251.61K
Credit Impairment Loss
31.42%-1.97M
-142.05%-4.87M
36.21%-4.59M
52.59%-2.61M
26.73%-2.87M
5.52%-2.01M
-42.79%-7.19M
---5.51M
---3.92M
---2.13M
Asset Impairment Loss
-24.49%-4.81M
-271.73%-1.61M
-64.00%-6.86M
-10.99%-3.7M
3.50%-3.86M
44.62%-432.15K
-85.42%-4.19M
---3.33M
---4M
---780.34K
Other net revenue
-3.64%7.92M
-133.66%-2.25M
379.50%12.54M
932.36%13.32M
1,911.79%8.22M
-258.97%-961.32K
-12.15%2.62M
1.29M
408.67K
604.72K
Fair value change income
--0
--13.77K
--33.95K
--32.43K
--0
--0
--0
--0
--0
----
Invest income
286.14%634.98K
1,062.69%246.76K
-5.01%770.34K
9.29%422.67K
-19.54%164.44K
-11.92%21.22K
-2.37%810.96K
--386.72K
--204.38K
--24.1K
Net open hedge income
--0
--0
--0
--0
--0
--0
--0
--0
--0
----
-Including: Investment income associates
--0
--0
--0
--0
--0
--0
--0
--0
--0
----
Exchange income
--0
--0
--0
--0
--0
--0
--0
--0
--0
----
Asset deal income
550.83%831.07K
1,473.56%637.29K
71.11%1.04M
-50.52%279.62K
-75.63%127.69K
-74.63%40.5K
222.81%610.61K
--565.1K
--524.08K
--159.66K
Other revenue
-9.74%13.23M
134.50%3.33M
76.12%22.14M
105.76%18.9M
92.90%14.66M
-57.36%1.42M
35.89%12.57M
--9.19M
--7.6M
--3.33M
Operating profit
32.22%102.73M
81.00%69.4M
-28.21%152.72M
29.99%118.28M
38.22%77.7M
59.66%38.34M
129.86%212.72M
47.79%91M
56.67%56.21M
38.57%24.01M
Add:Non operating Income
106.99%340.8K
-6.59%158.44K
-92.55%230.37K
-93.23%210.1K
-94.44%164.64K
121.70%169.61K
3.85%3.09M
--3.1M
--2.96M
--76.51K
Less:Non operating expense
273.60%1.01M
191.89%375.95K
34.52%1.45M
-46.41%552.15K
-58.22%269.08K
-70.37%128.8K
-17.89%1.07M
--1.03M
--643.98K
--434.62K
Total profit
31.55%102.07M
80.25%69.18M
-29.45%151.51M
26.72%117.94M
32.58%77.59M
62.25%38.38M
127.93%214.74M
46.16%93.07M
53.88%58.53M
31.86%23.66M
Less:Income tax cost
13.61%22.25M
80.85%16.68M
-37.92%33.83M
16.99%29.31M
19.15%19.59M
11.64%9.23M
122.54%54.48M
--25.05M
--16.44M
--8.26M
Net profit
37.60%79.81M
80.05%52.5M
-26.57%117.68M
30.31%88.63M
37.82%58M
89.42%29.16M
129.82%160.26M
46.88%68.02M
53.09%42.09M
38.87%15.39M
Net profit from continuing operation
37.60%79.81M
80.05%52.5M
-26.57%117.68M
30.31%88.63M
37.82%58M
89.42%29.16M
129.82%160.26M
--68.02M
--42.09M
--15.39M
Net income from discontinuing operating
----
--0
----
--0
----
--0
----
--0
----
----
Less:Minority Profit
2,951.10%6.84M
1,553.63%4.73M
682.12%3.01M
305.21%614.09K
-123.85%-240.04K
-580.25%-325.26K
-8,817.66%-517.88K
---299.25K
---107.23K
---47.81K
Net profit of parent company owners
25.29%72.97M
62.03%47.77M
-28.68%114.67M
28.84%88.02M
38.04%58.24M
90.94%29.48M
130.58%160.78M
47.48%68.31M
53.67%42.19M
40.05%15.44M
Earning per share
Basic earning per share
18.98%0.1824
45.79%0.1194
-38.30%0.29
13.29%0.2276
23.53%0.1533
80.40%0.0819
123.81%0.47
--0.2009
--0.1241
--0.0454
Diluted earning per share
18.98%0.1824
45.79%0.1194
-38.30%0.29
13.29%0.2276
23.53%0.1533
80.40%0.0819
123.81%0.47
--0.2009
--0.1241
--0.0454
Other composite income
0
2.13M
2.13M
2.13M
0
0
0
0
Other composite income of parent company owners
----
--0
--2.13M
--2.13M
--2.13M
--0
----
--0
--0
----
Other composite income of minority owners
----
--0
----
--0
----
--0
----
--0
----
----
Total composite income
32.72%79.81M
80.05%52.5M
-25.23%119.82M
33.45%90.77M
42.89%60.14M
89.42%29.16M
129.82%160.26M
68.02M
42.09M
15.39M
Total composite income of parent company owners
20.86%72.97M
62.03%47.77M
-27.35%116.8M
31.97%90.15M
43.10%60.38M
90.94%29.48M
130.58%160.78M
--68.31M
--42.19M
--15.44M
Total composite income of minority owners
2,951.10%6.84M
1,553.63%4.73M
682.12%3.01M
305.21%614.09K
-123.85%-240.04K
-580.25%-325.26K
-8,817.66%-517.88K
---299.25K
---107.23K
---47.81K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 25.21%2.17B30.60%1.1B16.39%3.8B19.71%2.68B22.80%1.73B24.91%845.61M39.50%3.26B39.17%2.24B36.90%1.41B35.28%676.98M
Operating revenue 25.21%2.17B30.60%1.1B16.39%3.8B19.71%2.68B22.80%1.73B24.91%845.61M39.50%3.26B39.17%2.24B36.90%1.41B35.28%676.98M
Other operating revenue 2.26%34.32M----22.53%74.42M----5.17%33.56M-----12.55%60.74M------31.91M----
Interest income --0----------0--0----------0--0----
Commission income --0--0--0--0--0--0--0--0--0----
Premiums earned --0--0--0--0--0--0--0--0--0----
Total operating cost 24.74%2.07B28.08%1.03B19.81%3.66B19.82%2.57B22.73%1.66B23.37%806.31M35.71%3.05B2.15B1.35B653.57M
Operating cost 24.50%1.48B29.96%741.62M19.73%2.63B19.52%1.83B24.10%1.19B25.35%570.67M44.41%2.2B--1.53B--955.87M--455.28M
Operating tax surcharges 65.13%10.23M61.59%4.98M-2.91%16.72M-4.84%10.55M-12.15%6.19M-8.98%3.08M31.20%17.22M--11.09M--7.05M--3.39M
Operating expense 22.83%467.5M23.53%229.48M22.18%804.47M26.46%592.82M24.33%380.61M21.20%185.76M18.29%658.43M--468.76M--306.13M--153.26M
Administration expense 21.53%92.5M13.76%45.54M5.59%158.51M0.42%114.83M5.33%76.12M13.34%40.03M14.20%150.12M--114.35M--72.27M--35.32M
Financial expense 26.36%10.13M3.56%4.9M-14.76%19.35M-23.75%13.57M-33.15%8.01M-21.97%4.73M-6.06%22.7M--17.8M--11.99M--6.06M
-Interest expense (Financial expense) 54.40%6.47M77.74%4.25M77.65%12.24M97.86%7.03M31.83%4.19M193.93%2.39M43.59%6.89M--3.55M--3.18M--812.6K
-Interest Income (Financial expense) -38.58%-8.9M-80.81%-4.63M-228.38%-14.07M-247.52%-7.88M-398.53%-6.42M-2,126.32%-2.56M-121.21%-4.28M---2.27M---1.29M---114.94K
Research and development 255.75%15.4M205.62%6.2M480.42%24.19M286.64%8.85M729.43%4.33M705.83%2.03M735.76%4.17M--2.29M--521.95K--251.61K
Credit Impairment Loss 31.42%-1.97M-142.05%-4.87M36.21%-4.59M52.59%-2.61M26.73%-2.87M5.52%-2.01M-42.79%-7.19M---5.51M---3.92M---2.13M
Asset Impairment Loss -24.49%-4.81M-271.73%-1.61M-64.00%-6.86M-10.99%-3.7M3.50%-3.86M44.62%-432.15K-85.42%-4.19M---3.33M---4M---780.34K
Other net revenue -3.64%7.92M-133.66%-2.25M379.50%12.54M932.36%13.32M1,911.79%8.22M-258.97%-961.32K-12.15%2.62M1.29M408.67K604.72K
Fair value change income --0--13.77K--33.95K--32.43K--0--0--0--0--0----
Invest income 286.14%634.98K1,062.69%246.76K-5.01%770.34K9.29%422.67K-19.54%164.44K-11.92%21.22K-2.37%810.96K--386.72K--204.38K--24.1K
Net open hedge income --0--0--0--0--0--0--0--0--0----
-Including: Investment income associates --0--0--0--0--0--0--0--0--0----
Exchange income --0--0--0--0--0--0--0--0--0----
Asset deal income 550.83%831.07K1,473.56%637.29K71.11%1.04M-50.52%279.62K-75.63%127.69K-74.63%40.5K222.81%610.61K--565.1K--524.08K--159.66K
Other revenue -9.74%13.23M134.50%3.33M76.12%22.14M105.76%18.9M92.90%14.66M-57.36%1.42M35.89%12.57M--9.19M--7.6M--3.33M
Operating profit 32.22%102.73M81.00%69.4M-28.21%152.72M29.99%118.28M38.22%77.7M59.66%38.34M129.86%212.72M47.79%91M56.67%56.21M38.57%24.01M
Add:Non operating Income 106.99%340.8K-6.59%158.44K-92.55%230.37K-93.23%210.1K-94.44%164.64K121.70%169.61K3.85%3.09M--3.1M--2.96M--76.51K
Less:Non operating expense 273.60%1.01M191.89%375.95K34.52%1.45M-46.41%552.15K-58.22%269.08K-70.37%128.8K-17.89%1.07M--1.03M--643.98K--434.62K
Total profit 31.55%102.07M80.25%69.18M-29.45%151.51M26.72%117.94M32.58%77.59M62.25%38.38M127.93%214.74M46.16%93.07M53.88%58.53M31.86%23.66M
Less:Income tax cost 13.61%22.25M80.85%16.68M-37.92%33.83M16.99%29.31M19.15%19.59M11.64%9.23M122.54%54.48M--25.05M--16.44M--8.26M
Net profit 37.60%79.81M80.05%52.5M-26.57%117.68M30.31%88.63M37.82%58M89.42%29.16M129.82%160.26M46.88%68.02M53.09%42.09M38.87%15.39M
Net profit from continuing operation 37.60%79.81M80.05%52.5M-26.57%117.68M30.31%88.63M37.82%58M89.42%29.16M129.82%160.26M--68.02M--42.09M--15.39M
Net income from discontinuing operating ------0------0------0------0--------
Less:Minority Profit 2,951.10%6.84M1,553.63%4.73M682.12%3.01M305.21%614.09K-123.85%-240.04K-580.25%-325.26K-8,817.66%-517.88K---299.25K---107.23K---47.81K
Net profit of parent company owners 25.29%72.97M62.03%47.77M-28.68%114.67M28.84%88.02M38.04%58.24M90.94%29.48M130.58%160.78M47.48%68.31M53.67%42.19M40.05%15.44M
Earning per share
Basic earning per share 18.98%0.182445.79%0.1194-38.30%0.2913.29%0.227623.53%0.153380.40%0.0819123.81%0.47--0.2009--0.1241--0.0454
Diluted earning per share 18.98%0.182445.79%0.1194-38.30%0.2913.29%0.227623.53%0.153380.40%0.0819123.81%0.47--0.2009--0.1241--0.0454
Other composite income 02.13M2.13M2.13M0000
Other composite income of parent company owners ------0--2.13M--2.13M--2.13M--0------0--0----
Other composite income of minority owners ------0------0------0------0--------
Total composite income 32.72%79.81M80.05%52.5M-25.23%119.82M33.45%90.77M42.89%60.14M89.42%29.16M129.82%160.26M68.02M42.09M15.39M
Total composite income of parent company owners 20.86%72.97M62.03%47.77M-27.35%116.8M31.97%90.15M43.10%60.38M90.94%29.48M130.58%160.78M--68.31M--42.19M--15.44M
Total composite income of minority owners 2,951.10%6.84M1,553.63%4.73M682.12%3.01M305.21%614.09K-123.85%-240.04K-580.25%-325.26K-8,817.66%-517.88K---299.25K---107.23K---47.81K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Notarized Tianye Certified Public Accountants (Special General Partnership)------Zhongtianyun Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg